HAPPYMINI® in the treatment of Temporo-Mandibular Osteoarthritis

Published by admin on


 

This prospective pilot study was conducted to show the Safety & Efficacy of a Single Injection of Mannitol-modified Cross-Linked Hyaluronic Acid (HAppyMini®) in the treatment of the Temporo-Mandibular Osteoartritis.

 

Results  at D180 :

  • Treatment was efficient or very efficient for 94% of the patients
  • Long lasting improvment of the inter-incisal distance 
  • 2/3 of patients reduced their painkillers / NSAIDs intake

 

UNIQUE COMBINATION OF
CROSS-LINKED HYALURONIC ACID + HIGHLY CONCENTRATED MANNITOL 

 

 

Click on the link below to see the ARTEMIS presentation displayed at the SFR 2018 Congress
By Dr Baron

 

ARTEMIS Study presentation